SynBioBeta

If your “hero strain” dies as soon as you hit 2,000 L, this one’s for you. Most cell factories still behave like black boxes at scale. Long development cycles, failed runs, and unpredictable performance make it hard for bio-made materials to compete. At Programmable Biology: The Digital Summit this Thursday, Relly Brandman and John Bachman of A-Life by X, The Moonshot Factory will share how they’re using AI models to make living factories predictable: • Turning noisy lab data into predictive models of strain performance • Flagging winners and losers before you invest in scale-up • Shortening development timelines while reducing failure rates and COGS risk • Connecting lab-scale discoveries to real-world manufacturing conditions 📅 Date: Thursday, Dec 11, 2025 💻 Format: Virtual | Free If you’re responsible for bioprocess development, tech transfer, or scale-up strategy, you won’t want to miss this conversation. Register now and join the conversation: https://lnkd.in/d5duebES

Biology suddenly has hundreds of large language models. Which ones actually work for the problems you care about when it’s hard to know what’s real signal vs. hype? At Programmable Biology: The Digital Summit, the team from Epoch AI — David Atanasov and Jaime Sevilla — will share a data-driven map of the biological LLM ecosystem, covering: • 360+ models across architectures, datasets, and compute • Where capabilities are plateauing (and where they’re still accelerating) • Which tasks bio-LLMs handle reliably today • Current blind spots in safety and evaluation If you’re biocurious or want to learn more about biology's current LLM landscape, do not miss out on this conversation. 📅 Thursday, Dec 11, 2025 🕘 09:00 AM PST 🌐 Virtual | Free Sign up now: https://lnkd.in/gfb-YdEy

Need better-performing enzymes for food, materials, or home-care products? The next competitive edge won’t come from discovering new proteins, but from designing them. Arzeda's Alexandre Zanghellini did machine learning on proteins before it was cool. Join him on thursday as he explores how AI and computational biology are enabling companies to create tailor-made proteins that deliver better performance, lower environmental impact, and entirely new product capabilities. From ingredient stability to material synthesis to home-care functionality, designed proteins are becoming a strategic lever for innovators across industries. If your team is rethinking its enzyme pipeline or exploring new functional ingredients, this is the session to watch. Register now! https://lnkd.in/d5duebES 📅 1PM PST | Thursday Dec 11, 2025 💻 Virtual & Free #Arzeda #ProteinDesign #IndustrialBiotech #FoodTech #Materials #ProgrammableBiology

1 WEEK LEFT until Programmable Biology: The Digital Summit! Have you signed up yet? Whether you’re a scientist, founder, investor, or technologist, this summit is your chance to step back and see the bigger picture of where programmable biology is heading. With live talks, candid Q&A, and space to connect with peers, you’ll spend the day with the people building the next generation of genome engineering, biopharma, AI, DNA synthesis, automation, biomanufacturing, and cell engineering. Speakers include: Robert Langer - Co-Founder (Moderna) Relly Brandman - Moonshot Lead & John Bachman - Science Lead (X, The Moonshot Factory - A-Life) Jason Chin - CSO & Ola (Aleksandra) Wlodek - CEO (Constructive Bio) Alexandre Zanghellini - CEO (Arzeda) Jacob Becraft - CEO (Strand Therapeutics) David Atanasov - Bioinformatics & Jaime Sevilla - Director (Epoch AI) John Cumbers - CEO & Founder, and Ivan R. Jaubert - Director of Entrepreneurship (SynBioBeta) Join us from 8:30AM to 3:00PM (Pacific Time), December 11. Learn more and register now! https://lnkd.in/d5duebES

The investors writing checks in AI and biology are at SynBioBeta this May. AIX Ventures. Khosla. Boom Capital. NFX. Playground Global. GSK, Sanofi, and J&J are sending their partnership teams. A deck is forgettable. Three days in San Jose is not. SynBioBeta 2026. May 4-7.